Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 21;11(10):1003-1009.
doi: 10.1093/stcltm/szac064.

CRISPRthripsis: The Risk of CRISPR/Cas9-induced Chromothripsis in Gene Therapy

Affiliations

CRISPRthripsis: The Risk of CRISPR/Cas9-induced Chromothripsis in Gene Therapy

Mario Amendola et al. Stem Cells Transl Med. .

Abstract

The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 nuclease system has allowed the generation of disease models and the development of therapeutic approaches for many genetic and non-genetic disorders. However, the generation of large genomic rearrangements has raised safety concerns for the clinical application of CRISPR/Cas9 nuclease approaches. Among these events, the formation of micronuclei and chromosome bridges due to chromosomal truncations can lead to massive genomic rearrangements localized to one or few chromosomes. This phenomenon, known as chromothripsis, was originally described in cancer cells, where it is believed to be caused by defective chromosome segregation during mitosis or DNA double-strand breaks. Here, we will discuss the factors influencing CRISPR/Cas9-induced chromothripsis, hereafter termed CRISPRthripsis, and its outcomes, the tools to characterize these events and strategies to minimize them.

Keywords: CRISPR/Cas9; chromosomal instability; chromothripsis; gene therapy; genome editing; genotoxicity; micronuclei.

PubMed Disclaimer

Figures

None
A DNA double-strand break can lead to the formation of acentric chromosome fragments and micronuclei. After DNA condensation, the chromosome fragment is shattered generating multiple DNA fragments, which are reincorporated in the nuclear genome forming a chromotriptic chromosome. If not reincorporated in the genome, these fragments can be lost (deleted fragments) or form double-minute chromosomes.
Figure 1.
Figure 1.
CRISPR/Cas9-induced events. The CRISPR/Cas9 complex is driven to a specific genomic site thanks to the complementarity of the gRNA to the target DNA region. Then, Cas9 induces a DNA double-strand break (DSB, red double arrow) 3-4 nucleotides upstream of the protospacer adjacent motif (PAM). This DSB can be repaired by the homology-directed repair (HDR) in the presence of a donor DNA or by non-homologous end joining (NHEJ) to generate InDels (insertion and deletions). However, if the DSB is not correctly repaired, one of the possible outcomes is CRISPRthripsis, with the formation of micronuclei containing an acentric chromosome fragment (light red box), chromosome bridges, and chromothriptic chromosomes (colored blocks represent shuffled DNA) (see Fig. 2).
Figure 2.
Figure 2.
Chromothripsis leads to massive genomic rearrangements. (A) A DNA double-strand break (DSB, red double arrow) can lead to the formation of an acentric chromosome fragment (light red box). After mitosis, this fragment can be enwrapped by a lipid membrane forming a micronucleus (red circle). After DNA condensation, the chromosome fragment is shattered generating multiple DNA fragments, which are eventually reassembled and reincorporated into the nuclear genome forming a chromotriptic chromosome. If not reincorporated in the genome, these fragments can be lost (deleted fragments) or form double-minute chromosomes. (B) A DNA DSB can lead to the formation of sister chromatids with shortened or absent telomeres that form a chromosomal bridge. During the first mitosis, cell division leads to breakage of the chromosomal bridge, which can induce local DNA fragmentation and chromothripsis. During the second mitosis, the broken chromosome missegregates, potentially leading to the formation of micronuclei, which also trigger chromothripsis (see panel A).

References

    1. Fu Y, Foden JA, Khayter C, et al. . High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol. 2013;31:822-826. 10.1038/nbt.2623 - DOI - PMC - PubMed
    1. Tsai SQ, Joung JK.. Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases. Nat Rev Genet. 2016;17:300-312. 10.1038/nrg.2016.28 - DOI - PMC - PubMed
    1. Boutin J, Cappellen D, Rosier J, et al. . ON-target adverse events of CRISPR-Cas9 nuclease: more chaotic than expected. CRISPR J. 2022;5:19-30. 10.1089/crispr.2021.0120 - DOI - PubMed
    1. Teboul L, Herault Y, Wells S, et al. . Variability in genome editing outcomes: challenges for research reproducibility and clinical safety. Mol Ther. 2020;28:1422-1431. 10.1016/j.ymthe.2020.03.015 - DOI - PMC - PubMed
    1. Parikh BA, Beckman DL, Patel SJ, et al. . Detailed phenotypic and molecular analyses of genetically modified mice generated by CRISPR-Cas9-mediated editing. PLoS One. 2015;10:e0116484. 10.1371/journal.pone.0116484 - DOI - PMC - PubMed

Publication types